Genomic Health Inc (GHDX) Return on Equity ROE from the third quarter 2019 to third quarter 2018 and annually, average high and low, overall ranking from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Genomic Health Inc  (NASDAQ: GHDX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Genomic Health Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Genomic Health Inc in the third quarter 2019?
Genomic Health Inc achieved a return on average equity (ROE) of 18.48 % in its third quarter 2019 a new company high.

ROE has advanced compared to 17.88% in the second quarter 2019, due to net income growth.

Within the Medical Laboratories industry 2 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2019 from 717 to 780.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Equity Change 42.01 % 40.86 % 43.66 % 43.48 % -
Y / Y Net Income Change 52.92 % 92.22 % - 374.19 % -
Net Income (TTM) in Millions 57 50 42 26 19
Return On Equity (TTM) 18.48 % 17.88 % 16.5 % 10.91 % 8.67 %
GHDX's Total Ranking # 780 # 717 # 711 # 1533 # 1625
Equity (TTM) in Millions 349 317 288 270 246
Seq. Equity Change 10.14 % 10.19 % 6.56 % 9.81 % 9.24 %
Seq. Net Income Change 16.93 % 22.99 % 45.89 % -27.12 % 46.99 %

Back to GHDX Management Effectiveness >> GHDX's 5 Years Annual ROE >> Compare GHDX ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 3
Sector # 84
Overall # 780

Return On Equity Statistics
High Average Low
18.48 %
-6.04 %
-25.18 %
(Sep 30 2019)   (Sep 30 2015)





GHDX Annual Return On Equity (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Equity in Millions 270 188 156 140 146
Y / Y Equity Change 43.48 % 20.62 % 11.88 % -4.11 % 0.37 %
Net Income in Millions 26 -4 -14 -33 -25
Y / Y Net Income Change - - - - -
Return On Equity 9.5 % -2.05 % -8.92 % -23.87 % -16.9 %

Back to GHDX Management Effectiveness >> GHDX's 5 Years Annual ROE >> Compare GHDX ROE to its Competitors




Annual Roe Comment
In 2018 ROE improved to 9.5 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GHDX's' Return on Equity at Yahoo Finance
GHDX's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GHDX's Competitors
Subscribers only: Roe for Genomic Health Inc's Suppliers
Subscribers only: Return On Equity for GHDX's Customers




Companies with similar Return On Equity at Sep 30 2019, within Healthcare Sector ROE
3m Company  48.98 %
Siga Technologies Inc  47.82 %
Strongbridge Biopharma plc  45.77 %
Remedent Inc   43.59 %
Vertex Pharmaceuticals Inc  43.50 %
Adaptive Biotechnologies Corporation  42.61 %
Exelixis Inc   42.49 %
Biogen Inc   40.11 %
Lantheus Holdings Inc   39.71 %
Vanda Pharmaceuticals Inc   38.90 %
Contrafect Corporation  38.39 %
Bristol myers Squibb Company  35.85 %
Arrowhead Pharmaceuticals Inc   35.52 %
Chemed Corporation  33.79 %
Merck and Co Inc   33.66 %
Fonar Corporation  33.39 %
Align Technology inc   32.30 %
Lifevantage Corp  31.99 %
Ionis Pharmaceuticals Inc   29.54 %
Corcept Therapeutics Inc  29.08 %
Stryker Corp  28.74 %
Pfizer Inc  26.18 %
U S Physical Therapy Inc  26.01 %
Tenet Healthcare Corp  25.25 %
Encompass Health Corporation  25.09 %
Johnson and Johnson  23.81 %
Amedisys Inc  23.53 %
Abiomed Inc   23.35 %
Bruker Corporation  23.33 %
Illumina Inc   22.75 %

Date modified: 2026-09-26T07:02:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.